We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Alterity Therapeutics Limited | NASDAQ:ATHE | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.04 | -2.00% | 1.96 | 1.85 | 2.25 | 2.0054 | 1.85 | 1.97 | 34,078 | 21:37:59 |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-163
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2023
Alterity Therapeutics Limited
(Name of Registrant)
Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-251647, 333-249311, 333-231417 and 333-250076)
ALTERITY THERAPEUTICS LIMITED
(a development stage enterprise)
The following exhibits are submitted:
99.1 | Notification of cessation of securities – ATH |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Alterity Therapeutics Limited | ||
/s/ Geoffrey P. Kempler | ||
By: | Geoffrey P. Kempler | |
Chairman |
Date: september 13, 2023
2
Exhibit 99.1
Notification of cessation of +securities |
Announcement Summary
Entity name
ALTERITY THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
Wednesday September 13, 2023
Details of +securities that have ceased
ASX+security code |
Security description |
Number of +securities that have ceased |
The +securities have ceased due to | Date of cessation | ||||
ATHAAG |
OPTION EXPIRING 29-NOV-2026 EX $0.0238 |
500,000 | Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied | 11/09/2023 |
Refer to next page for full details of the announcement
Notification of cessation of +securities | 1/4 |
Notification of cessation of +securities |
Part 1 - Announcement Details
1.1 Name of +Entity
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) provide the following information about our issued capital.
1.2 Registered Number Type | Registration Number | ||
ABN | 37080699065 |
1.3 ASX issuer code
ATH
1.4 The announcement is
þ New announcement
1.5 Date of this announcement
13/9/2023
Notification of cessation of +securities | 2/4 |
Notification of cessation of +securities |
Part 2 - Details of +equity securities or +debt securities that have ceased
ASX +Security Code and Description
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238
Unquoted +equity securities that have ceased
Number of securities that have ceased
500,000
Reason for cessation
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied
Date of cessation | Is the entity paying any consideration for the cessation? | ||
11/9/2023 | þ No |
Any other information the entity wishes to notify to ASX about the cessation?
Notification of cessation of +securities | 3/4 |
Notification of cessation of +securities |
Part 3 - Issued capital following changes
Following the cessation of the + securities the subject of this notification, the issued capital of the entity will comprise:
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
ASX +security code and description | Total number of | |||
ATH : ORDINARY FULLY PAID | 2,439,897,618 |
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
ASX +security code and description | Total number of +securities on issue | |||
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 | 19,250,000 | |||
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 | 12,000,000 | |||
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 | 11,900,000 | |||
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 | 35,000,000 | |||
ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07 | 674,694,939 | |||
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 | 91,392,720 |
Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.
Notification of cessation of +securities | 4/4 |
1 Year Alterity Therapeutics Chart |
1 Month Alterity Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions